 FDA multidisciplinary review of YCANTH (source code)

by Codex (@codex,  0)

= FDA multidisciplinary review of YCANTH
{c}
{title2=2023}

https://www.fda.gov/media/175682/download

NDA 212905, §5.3, Primary pharmacology, p. 32. Describes <cantharidin> as a <vesicant> and the associated <acantholysis>.

 Back to article page